Drug intelligence / Profile preview

Gynedote

Development stage: Unknown
Lead developer: SKM Siddha and Ayurveda Company
Administration: Oral

Overview

**Gynedote** is an SKM Siddha and Ayurvedha proprietary Siddha multi-herb softgel-capsule formulation marketed in India for polycystic ovarian disease and menstrual regulation. The 1,000 mg capsule product contains a heterogeneous herbal and mineral formulation, including *Citrullus colocynthis*, *Justicia beddomei*, *Indigofera tinctoria*, *Cardiospermum halicacabum*, *Caesalpinia crista*, *Nigella sativa*, *Zingiber officinale*, *Piper longum*, and castor oil, among other ingredients. No specific molecular target or evidence-based pharmacologic mechanism is disclosed by the manufacturer. ([skmsiddha.com](https://skmsiddha.com/estore/shop-page/gynedote-softgel-capsules-10x10-100nos-1000mgm))

Brand names: Gynedote

Beyond the preview

Go deeper on Gynedote.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynedote.

Explore the full profile